Skip to content

The Archive · A Source

Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial

Compass Pathways 2026 ir.compasspathways.com/News--Events-/news/news-details/2026/Compass-Pathways-Successfully-Achieves-Primary-Endpoint-in-Second-Phase-3-Trial-Evaluating-COMP360-Psilocybin-for-Treatment-Resistant-Depression/default.aspx